Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS

NCT: NCT06076499 · ACTIVE_NOT_RECRUITING

NCT IDNCT06076499
StatusACTIVE_NOT_RECRUITING
Start Date2023-11-15
Completion2027-07

Brief Summary

Multi-center post-market, observational study to assess the long-term effectiveness and safety of the NTX100 TOMAC System for patients with Restless Legs Syndrome.

Frequently Asked Questions

What is A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS?

A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS is a clinical trial registered under NCT06076499. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06076499?

The current status of NCT06076499 (A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS) is: ACTIVE_NOT_RECRUITING.

When did A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS start?

A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS started on 2023-11-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑